Literature DB >> 30054853

The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.

Patrick A Carroll1, Brian W Freie1, Haritha Mathsyaraja1, Robert N Eisenman2.   

Abstract

Transcription factor networks have evolved in order to control, coordinate, and separate, the functions of distinct network modules spatially and temporally. In this review we focus on the MYC network (also known as the MAX-MLX Network), a highly conserved super-family of related basic-helix-loop-helix-zipper (bHLHZ) proteins that functions to integrate extracellular and intracellular signals and modulate global gene expression. Importantly the MYC network has been shown to be deeply involved in a broad spectrum of human and other animal cancers. Here we summarize molecular and biological properties of the network modules with emphasis on functional interactions among network members. We suggest that these network interactions serve to modulate growth and metabolism at the transcriptional level in order to balance nutrient demand with supply, to maintain growth homeostasis, and to influence cell fate. Moreover, oncogenic activation of MYC and/or loss of a MYC antagonist, results in an imbalance in the activity of the network as a whole, leading to tumor initiation, progression and maintenance.

Entities:  

Keywords:  MAX; MLX; MYC; cancer; network; transcription

Mesh:

Substances:

Year:  2018        PMID: 30054853     DOI: 10.1007/s11684-018-0650-z

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  120 in total

1.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Authors:  Franz X Schaub; Varsha Dhankani; Ashton C Berger; Mihir Trivedi; Anne B Richardson; Reid Shaw; Wei Zhao; Xiaoyang Zhang; Andrea Ventura; Yuexin Liu; Donald E Ayer; Peter J Hurlin; Andrew D Cherniack; Robert N Eisenman; Brady Bernard; Carla Grandori
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

3.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain.

Authors:  A R Ferré-D'Amaré; G C Prendergast; E B Ziff; S K Burley
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

Review 4.  Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks.

Authors:  John M O'Shea; Donald E Ayer
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 6.  Taming of the beast: shaping Myc-dependent amplification.

Authors:  Elmar Wolf; Charles Y Lin; Martin Eilers; David L Levens
Journal:  Trends Cell Biol       Date:  2014-12-01       Impact factor: 20.808

7.  High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.

Authors:  Jennifer Edelmann; Karlheinz Holzmann; Florian Miller; Dirk Winkler; Andreas Bühler; Thorsten Zenz; Lars Bullinger; Michael W M Kühn; Andreas Gerhardinger; Johannes Bloehdorn; Ina Radtke; Xiaoping Su; Jing Ma; Stanley Pounds; Michael Hallek; Peter Lichter; Jan Korbel; Raymonde Busch; Daniel Mertens; James R Downing; Stephan Stilgenbauer; Hartmut Döhner
Journal:  Blood       Date:  2012-10-09       Impact factor: 22.113

8.  hMad4, c-Myc endogenous inhibitor, induces a replicative senescence-like state when overexpressed in human fibroblasts.

Authors:  Richard Marcotte; Jing-Fang Qian; James Chen; Eugenia Wang
Journal:  J Cell Biochem       Date:  2003-06-01       Impact factor: 4.429

9.  Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?

Authors:  G Meroni; S Cairo; G Merla; S Messali; R Brent; A Ballabio; A Reymond
Journal:  Oncogene       Date:  2000-07-06       Impact factor: 9.867

10.  The T protein encoded by Brachyury is a tissue-specific transcription factor.

Authors:  A Kispert; B Koschorz; B G Herrmann
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  81 in total

1.  MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.

Authors:  Arnaud Augert; Haritha Mathsyaraja; Ali H Ibrahim; Brian Freie; Michael J Geuenich; Pei-Feng Cheng; Sydney P Alibeckoff; Nan Wu; Joseph B Hiatt; Ryan Basom; Adi Gazdar; Lucas B Sullivan; Robert N Eisenman; David MacPherson
Journal:  Cancer Cell       Date:  2020-05-28       Impact factor: 31.743

Review 2.  Polyamine synthesis as a target of MYC oncogenes.

Authors:  André S Bachmann; Dirk Geerts
Journal:  J Biol Chem       Date:  2018-11-07       Impact factor: 5.157

3.  Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

Authors:  Chenfeng Wang; Yang Yang; Guang Zhang; Jingxin Li; Xianning Wu; Xiaoling Ma; Ge Shan; Yide Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

4.  Getting MAD at MYC.

Authors:  Maria Letizia Giardino Torchia; Jonathan D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

Review 5.  CSN6: a promising target for cancer prevention and therapy.

Authors:  Jianbing Hou; Hongjuan Cui
Journal:  Histol Histopathol       Date:  2020-02-04       Impact factor: 2.303

6.  MYC needs MNT to drive B cells over the edge.

Authors:  Siegfried Janz
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

7.  Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.

Authors:  Giovanna Zinzalla
Journal:  Methods Mol Biol       Date:  2021

Review 8.  Low-Affinity Binding Sites and the Transcription Factor Specificity Paradox in Eukaryotes.

Authors:  Judith F Kribelbauer; Chaitanya Rastogi; Harmen J Bussemaker; Richard S Mann
Journal:  Annu Rev Cell Dev Biol       Date:  2019-07-05       Impact factor: 13.827

Review 9.  Targeting "undruggable" c-Myc protein by synthetic lethality.

Authors:  Chen Wang; Hui Fang; Jiawei Zhang; Ying Gu
Journal:  Front Med       Date:  2021-03-04       Impact factor: 4.592

Review 10.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.